Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059082 · ClinicalTrials.gov registry record · NA
A Critical Illness Recovery Navigator for Alcohol
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03059082: Clinical Trial NA study, sponsored by University of Colorado, Denver.
NCT03059082 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03059082, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Excessive alcohol consumption is common in patients admitted to the intensive care unit (ICU). Among patients who survive an ICU admission, excessive alcohol consumption is associated with a higher risk of being admitted the hospital. In this study, the Investigators will compare an intervention designed to address excessive drinking in ICU survivors to usual care. This intervention combines motivational interviewing (MI) and shared decision making (SDM). MI and SDM share several core components including the development of a therapeutic alliance and promotion of autonomy. MI can be employed in the context of motivating a patient to change their drinking. Once this decision has been made, SDM can be employed to help a patient decide amongst multiple reasonable treatment options. The Investigators long-term goal is to test whether MI-SDM is better than usual care and whether multiple sessions of MI-SDM are better than a single session. This pilot clinical trial will demonstrate the feasibility of conducting a larger efficacy study to test these hypotheses.
Primary Outcome
Client satisfaction questionnaire (CSQ-8), with revisions to make it specific to the objectives of this study.
Interventions
- BEHAVIORAL Recovery Navigator on an as needed basis up to 6 months
- BEHAVIORAL Recovery Navigator prior to hospital discharge
- OTHER No interaction with Recovery Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Why NCT03059082 stopped before completion
NCT03059082 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Recovery Navigator on an as needed basis up to 6 months is the first listed.
NCT03059082 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03059082 about?
NCT03059082 is a clinical study titled "A Critical Illness Recovery Navigator for Alcohol". Excessive alcohol consumption is common in patients admitted to the intensive care unit (ICU). Among patients who survive an ICU admission, excessive alcohol consumption is associated with a higher risk of being admitted the hospital. In this study, the Investigators will compare an intervention des...
What is the current status of trial NCT03059082?
This trial is currently terminated. It is a NA study. The enrollment target is 47 participants. The study started on 2016-12. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT03059082?
The interventions under investigation include: Recovery Navigator on an as needed basis up to 6 months (BEHAVIORAL), Recovery Navigator prior to hospital discharge (BEHAVIORAL), No interaction with Recovery Navigator (OTHER).
Who is sponsoring clinical trial NCT03059082?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03059082's enrollment target sits among peer trials
47 1400th of 2000 higher than 599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia